IP Library › Patent Application 13424111
Patent Application
App. No. 13/424,111

RAF KINASE INHIBITORS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/424,111
Abstract

Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.

Claims (17)

1 . A method for the treatment of cancerous cell growth mediated by raf kinase, comprising administering a compound of the formulae:

2 . A method according to claim 1 , comprising administering a compound of the formulae

3 . A method according to claim 1 , comprising administering a compound of the formula

4 . A method according to claim 1 , comprising administering a compound of formulae

5 . A method according to claim 1 , comprising administering a compound of formulae

6 . A method according to claim 1 , comprising administering a compound of formulae

7 . A method according to claim 1 , comprising administering a compound of formulae

8 . A compound of the formulae

9 . A compound according to claim 8 , of the formulae

10 . A compound according to claim 8 , of the formulae

11 . A compound according to claim 8 , of the formulae

12 . A compound according to claim 8 , of the formulae

13 . A compound according to claim 8 , of the formulae

14 . A compound according to claim 8 , of the formulae

15 . A pharmaceutical composition comprising a compound according to claim 8 and a physiologically acceptable carrier.

16 . A pharmaceutical composition comprising a compound according to claim 14 and a physiologically acceptable carrier.

17 . A pharmaceutical composition comprising a compound according to claim 8 and a physiologically acceptable carrier, in sterile form.